tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Lichen Nitidus D017513 1 associated lipids
Pityriasis Lichenoides D017514 2 associated lipids
Mucinoses D017520 2 associated lipids
Lung Diseases, Interstitial D017563 5 associated lipids
Myelinolysis, Central Pontine D017590 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Lichen Planus, Oral D017676 2 associated lipids
Cytomegalovirus Retinitis D017726 2 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Glucose Intolerance D018149 13 associated lipids
Flaviviridae Infections D018178 1 associated lipids
Cardiovirus Infections D018188 3 associated lipids
Fibroadenoma D018226 2 associated lipids
Smooth Muscle Tumor D018235 1 associated lipids
Seminoma D018239 2 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Angiofibroma D018322 2 associated lipids
Hutchinson's Melanotic Freckle D018327 2 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Lichen Sclerosus et Atrophicus D018459 2 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cryptogenic Organizing Pneumonia D018549 3 associated lipids
Hypoplastic Left Heart Syndrome D018636 1 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Multiple Endocrine Neoplasia Type 2a D018813 1 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Fasciitis, Necrotizing D019115 1 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Oral Ulcer D019226 1 associated lipids
Endotoxemia D019446 27 associated lipids
Pouchitis D019449 3 associated lipids
Dermatitis, Perioral D019557 4 associated lipids
Intracranial Hypertension D019586 4 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Hepatitis, Autoimmune D019693 1 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Miller Fisher Syndrome D019846 1 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Epstein-Barr Virus Infections D020031 3 associated lipids
Hepatopulmonary Syndrome D020065 1 associated lipids
Citrullinemia D020159 1 associated lipids
Sleep Apnea, Central D020182 1 associated lipids
Nocturnal Myoclonus Syndrome D020189 1 associated lipids
Trauma, Nervous System D020196 2 associated lipids
Facial Nerve Injuries D020220 1 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Hypertensive Encephalopathy D020343 1 associated lipids
Paraneoplastic Syndromes, Nervous System D020361 1 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Peroneal Neuropathies D020427 1 associated lipids
Brain Infarction D020520 17 associated lipids
Stroke D020521 32 associated lipids
Nervous System Autoimmune Disease, Experimental D020721 3 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Intracranial Thrombosis D020767 2 associated lipids
Central Nervous System Viral Diseases D020805 1 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Neuroaspergillosis D020953 2 associated lipids
Brachial Plexus Neuritis D020968 2 associated lipids
Lacerations D022125 1 associated lipids
Coronary Stenosis D023921 6 associated lipids
Polyomavirus Infections D027601 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Papillomavirus Infections D030361 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Hypoalbuminemia D034141 1 associated lipids
Mastocytosis, Cutaneous D034701 1 associated lipids
Cholecystolithiasis D041761 2 associated lipids
Intestinal Volvulus D045822 1 associated lipids
Ileus D045823 3 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Protoporphyria, Erythropoietic D046351 1 associated lipids
Colitis, Collagenous D046729 1 associated lipids
Hepatic Insufficiency D048550 1 associated lipids
Diabetes Complications D048909 4 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Granulomatosis, Orofacial D051261 2 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Renal Insufficiency D051437 8 associated lipids
Delayed Graft Function D051799 2 associated lipids
Nocturia D053158 1 associated lipids
Dysuria D053159 1 associated lipids
Posterior Leukoencephalopathy Syndrome D054038 1 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Failed Back Surgery Syndrome D055111 3 associated lipids
Pancreatitis, Graft D055589 1 associated lipids
Multiple Pulmonary Nodules D055613 2 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Persić-Vojinović S et al. Disseminated Hailey-Hailey disease treated with topical tacrolimus and oral erythromycin: Case report and review of the literature. 2006 Acta Dermatovenerol Croat pmid:17311740
Louvain D et al. Lichen sclerosus in the oral mucosa: a rare form of presentation. 2012 Acta Dermatovenerol Croat pmid:22507475
Lipozencić J Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases. 2005 Acta Dermatovenerol Croat pmid:15788149
Pustisek N et al. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature. 2002 Acta Dermatovenerol Croat pmid:12137728
Polastri L et al. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. 2002 Acta Diabetol pmid:12486498
Sato M et al. FK506 inhibits phytohemagglutinin-, but not interferon-gamma-, induced HLA-DR antigen expression and accessory cell function on primary cultured human thyroid cells. 1993 Acta Endocrinol. pmid:7509103
Pirenne J Contribution of large animal models to the development of clinical intestinal transplantation. 1999 Apr-Jun Acta Gastroenterol. Belg. pmid:10427786
Jamieson NV Adult small intestinal transplantation in Europe. 1999 Apr-Jun Acta Gastroenterol. Belg. pmid:10427790
Bonaccorsi-Riani E et al. Impact of steroid-avoidance immunosuppression on long-term outcome after liver transplantation for HCV cirrhosis: the need for well documented long-term follow-up. 2012 Acta Gastroenterol. Belg. pmid:23402084
Reding R et al. Stepwise minimization of the immunosuppressive therapy in pediatric liver transplantation. A conceptual approach towards operational tolerance. 2005 Jul-Sep Acta Gastroenterol. Belg. pmid:16268418
Varela E [Small bowel transplantation]. 1995 Acta Gastroenterol. Latinoam. pmid:7544939
Okada M et al. Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation. 1999 Acta Haematol. pmid:10529517
Kraus TS et al. Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient. 2014 Acta Haematol. pmid:24157860
Mesar I et al. [Outcome of renal transplantation after tacrolimus switch to cyclosporine]. 2011 Acta Med Croatica pmid:22359902
Wardhana EA and Datau A patient with plaque type morphea mimicking systemic lupus erythematosus. 2015 Acta Med Indones pmid:26260557
Kuinose M et al. Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions. 2000 Acta Med. Okayama pmid:11061569
Takagi K et al. Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Liver Transplantation. 2017 Acta Med. Okayama pmid:28238015
Tanaka K et al. Immunophilin ligands prevent H2O2-induced apoptotic cell death by increasing glutathione levels in neuro 2A neuroblastoma cells. 2000 Acta Med. Okayama pmid:11132921
Setkowicz Z and Guzik R Injections of vehicle, but not cyclosporin A or tacrolimus (FK506), afford neuroprotection following injury in the developing rat brain. 2007 Acta Neurobiol Exp (Wars) pmid:18320718
Luchowska E et al. FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices. 2003 Acta Neurobiol Exp (Wars) pmid:12926536
Yildirim FB et al. Effect of FK506 administration after obturator nerve injury: a functional and ultrastructural study. 2008 Acta Neurobiol Exp (Wars) pmid:19112470
Ishikawa Y et al. Search for novel gene markers of traumatic brain injury by time differential microarray analysis. 2006 Acta Neurochir. Suppl. pmid:16671447
Uchino H et al. Calcineurin and cyclophilin D are differential targets of neuroprotection by immunosuppressants CsA and FK506 in ischemic brain damage. 2003 Acta Neurochir. Suppl. pmid:14753416
Katsura KI et al. FK506 attenuates the post-ischemic perturbation of protein kinases and tyrosine phosphorylation in the gerbil hippocampal CA1 sectors. 2003 Acta Neurochir. Suppl. pmid:14753417
Mitsui T et al. The effects of FK506 on refractory inflammatory myopathies. 2011 Acta Neurol Belg pmid:22141281
Ogul H et al. Severe toxic leukoencephalopathy associated with tacrolimus after living donor liver transplantation. 2015 Acta Neurol Belg pmid:24854146
Miura S et al. Combined treatment with prednisolone and tacrolimus for myasthenia gravis with invasive thymoma. 2010 Acta Neurol Belg pmid:20514937
Díaz-García C et al. First report on fertility after allogeneic uterus transplantation. 2010 Acta Obstet Gynecol Scand pmid:20879912
Kortekangas-Savolainen O and Kiilholma P Treatment of vulvovaginal erosive and stenosing lichen planus by surgical dilatation and methotrexate. 2007 Acta Obstet Gynecol Scand pmid:17364310
Jongen VH et al. Vaginal delivery after lung transplantation. 2000 Acta Obstet Gynecol Scand pmid:11130101
Helgesen AL et al. Vaginal involvement in genital erosive lichen planus. 2010 Acta Obstet Gynecol Scand pmid:20583940
Hellström VC et al. Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study. 2016 Acta Oncol pmid:26824275
Remitz A et al. Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure. 2011 Acta Ophthalmol pmid:20064110
Virtanen HM et al. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. 2006 Acta Ophthalmol Scand pmid:16965503
Shibatani M et al. Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head. 2008 Acta Orthop pmid:18839369
Fukunaga T et al. Osteogenesis in xenogeneic bone transplantation, using an immunosuppressant. Rabbit-rat experiments. 1995 Acta Orthop Scand pmid:8553828
Muramatsu K et al. Longer survival of rat limb allograft. Combined immunosuppression of FK-506 and 15-deoxyspergualin. 1997 Acta Orthop Scand pmid:9462361
Ikebe S et al. Immunosuppressive effect of tacrolimus (FK-506). Bone xenografts in rabbits. 1996 Acta Orthop Scand pmid:8792745
Bas E et al. An experimental comparative study of dexamethasone, melatonin and tacrolimus in noise-induced hearing loss. 2009 Acta Otolaryngol. pmid:19051071
Azuma H et al. Atypical Epstein-Barr virus infection during and after intermittent FK506 therapy. 1997 Acta Paediatr Jpn pmid:9141259
Matsui A et al. Apparently increased trough levels of tacrolimus caused by acute infantile diarrhea in two infants with biliary atresia after liver transplantation. 1996 Acta Paediatr Jpn pmid:9002314
Bienemann K et al. Topical tacrolimus is effective against eczema in Wiskott-Aldrich syndrome (WAS). 2007 Acta Paediatr. pmid:17429928
Sinha R and Marks SD Tacrolimus toxicity secondary to diarrhoea in nephrotic syndrome. 2013 Acta Paediatr. pmid:23573873
Isidor B et al. Hyperzincemia and hypercalprotectinemia: unsuccessful treatment with tacrolimus. 2009 Acta Paediatr. pmid:18983438
Marlaka JR et al. Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis. 2012 Acta Paediatr. pmid:22646819
Gradman J and Wolthers OD Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus. 2007 Acta Paediatr. pmid:17590198
Puzik A et al. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells. 2007 Acta Paediatr. pmid:17880416
Wang YP et al. Novel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: in vitro evaluation and in vivo bioavailability test. 2011 Acta Pharmacol. Sin. pmid:21927013
Lu YX et al. A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. 2015 Acta Pharmacol. Sin. pmid:25500866
Chen JC and Ma P Mechanism of FK506-induced renal hypoperfusion and its reversion in rats. 2001 Acta Pharmacol. Sin. pmid:11749797